About the Authors

Bas Cornelis Jansen

Roles Conceptualization, Software, Validation, Writing – original draft, Writing – review & editing

bas.jansen@ludger.com

Affiliation Research & Development, Ludger Limited., Abingdon, Oxfordshire, United Kingdom

Lise Hafkenscheid

Roles Validation, Writing – original draft

Affiliation Department of Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands

Albert Bondt

Roles Supervision, Validation, Writing – original draft, Writing – review & editing

Affiliations Department of Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands, Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands

Richard Andrew Gardner

Roles Validation, Writing – original draft, Writing – review & editing

Affiliation Research & Development, Ludger Limited., Abingdon, Oxfordshire, United Kingdom

Jenifer Lynn Hendel

Roles Validation, Writing – original draft

Affiliation Research & Development, Ludger Limited., Abingdon, Oxfordshire, United Kingdom

Manfred Wuhrer

Roles Supervision, Writing – original draft, Writing – review & editing

Affiliation Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands

Daniel Ian Richard Spencer

Roles Supervision, Writing – original draft, Writing – review & editing

Affiliation Research & Development, Ludger Limited., Abingdon, Oxfordshire, United Kingdom

Competing Interests

The authors have declared that no competing interests exist. The software published in this article has been partially developed at Ludger. However, the software is released completely open source which is why the authors have declared no competing interests. BCJ, RAG, JLH and DIRS work for Ludger Ltd – a commercial company that specialises in the development and validation of glycoprofiling technology for biologic therapeutics and biological tissues. Some of the Ludger products include glycan purification kits and glycan release kits. There are no patents and products in development. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.